BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making

SIMPLE SUMMARY: In this retrospective observational study, we evaluated data from patients with triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NACT) in order to better define the impact of germline BRCA1/2 (gBRCA1/2) mutation status on outcomes in this patient population...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavese, Francesco, Capoluongo, Ettore Domenico, Muratore, Margherita, Minucci, Angelo, Santonocito, Concetta, Fuso, Paola, Concolino, Paola, Di Stasio, Enrico, Carbognin, Luisa, Tiberi, Giordana, Garganese, Giorgia, Corrado, Giacomo, Di Leone, Alba, Generali, Daniele, Fragomeni, Simona Maria, D’Angelo, Tatiana, Franceschini, Gianluca, Masetti, Riccardo, Fabi, Alessandra, Mulè, Antonino, Santoro, Angela, Belli, Paolo, Tortora, Giampaolo, Scambia, Giovanni, Paris, Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559391/
https://www.ncbi.nlm.nih.gov/pubmed/36230495
http://dx.doi.org/10.3390/cancers14194571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559391/
https://www.ncbi.nlm.nih.gov/pubmed/36230495
http://dx.doi.org/10.3390/cancers14194571

Ejemplares similares